Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target.

Greulich, Benjamin M; Plotnik, Joshua P; Jerde, Travis J; Hollenhorst, Peter C

Greulich, Benjamin M; Plotnik, Joshua P; Jerde, Travis J; Hollenhorst, Peter C.

Afiliación

Greulich BM; Medical Sciences, Indiana University School of Medicine, Bloomington, IN 47405, USA.
Plotnik JP; Biology Department, Indiana University, Bloomington, IN 47405, USA.
Jerde TJ; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Hollenhorst PC; Medical Sciences, Indiana University School of Medicine, Bloomington, IN 47405, USA.

NAR Cancer ; 3(1): zcaa046, 2021 Mar.

Article en En | MEDLINE | ID: mdl-33554122

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NAR Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google